跳至主要内容
临床试验/NCT07480655
NCT07480655招募中4 期

Evaluation of Effect of Pv-aCO2-Gap on Clinical Outcomes With Standard Resuscitation End-points in Adult Poly-trauma Patients Admitted to the ICU --- Prospective Randomized Control Trial

Pakistan Institute of Medical Sciences1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2026年3月16日最近更新:
干预措施

试验速览

阶段
4 期
状态
招募中
入组人数
60
试验地点
1
主要终点
Length of mechanical ventilation

研究概览

简要总结

dult patients with multiple traumatic injuries admitted to the ICU from the operating room, emergency department, or hospital wards who meet the study criteria will be included after obtaining informed consent from the patient or their legal guardian. Participants will be randomly divided into two groups: one group will receive treatment guided by the difference between carbon dioxide levels in venous and arterial blood, while the other group will receive treatment based on standard resuscitation parameters commonly used in critical care. As part of routine monitoring, all patients will have a central venous catheter and an arterial line inserted to measure blood parameters. Blood samples from both lines will be taken shortly after ICU admission and at regular intervals during the first three days. These samples will be analyzed using a bedside blood gas machine, and the results will be compared between the two groups to determine whether monitoring the difference in carbon dioxide levels between venous and arterial blood improves patient outcomes compared with standard care.

详细描述

All polytrauma patients admitted to the ICU from the operating theater, emergency department, or hospital wards who fulfill the inclusion criteria will be enrolled in the study after obtaining written informed consent from the patients or their legal representatives. Participants will be randomized in a 1:1 ratio using a computer-generated method into two groups: an intervention group managed with a Pv-aCO₂ gap-targeted approach and a control group managed according to standard resuscitation end-points. As part of routine hemodynamic monitoring in critical care, a central venous catheter (two- or three-lumen catheter-Arrow) and an arterial catheter (Arterial Leader Cath-Vygon or Teleflex) will be inserted in all participants before or immediately after ICU admission. After insertion, the position of the central venous catheter tip at the junction of the superior vena cava and right atrium will be confirmed by chest X-ray. Arterial and venous blood samples for blood gas analysis (ABGA and VBGA) will be obtained in the ICU using a point-of-care gas analyzer (ABL800 FLEX®, Radiometer) within 1 hour of ICU admission and subsequently at 6, 12, 24, 48, and 72 hours. The time interval between arterial and venous blood sampling will be kept under 5 minutes to minimize bias, and the measurements obtained at different time points will be compared with standard resuscitation end-points.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Either Gender
  • Poly-trauma patients
  • ○ Both penetrating and blunt trauma
  • Both surgical and non-surgical
  • Shock States

排除标准

  • Any Chest trauma
  • Patients with Obstructive and restrictive lung disease
  • Obstructive sleep apnea
  • Septic shock
  • Pregnant patients
  • Patients who will require readmission within 48 h after step-down from the ICU.
  • Patients who will need extra-corporeal membrane oxygenation support

研究组 & 干预措施

Carbondioxide gap group

Experimental

干预措施: Veno-arterial Carbondioxide gap (Diagnostic Test)

Conventional resuscitation group

Active Comparator

干预措施: Conventional resuscitation end points (Diagnostic Test)

结局指标

主要结局

Length of mechanical ventilation

时间窗: This will be the number of days of ventilatory support once patient is admitted to ICU

次要结局

  • ICU stay(This will the total length of ICU stay measured in number of days)
  • qSOFA score(This will be measured at time of admission in ICU then at 48h and 72h following admission)
  • ICU Mortality(This will be the death occurring during ICU stay)

研究者

申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Muhammad Haroon Anwar

Principal Investigator

Pakistan Institute of Medical Sciences

研究点 (1)

Loading locations...

相似试验